It is a pharma public limited company based in Kanukunta Village, Telangana, India, established in 1982.
1982 | Kanukunta Village, Telangana, India | ActiveSudershan Drugs And Intermediates Limited, a active public limited company, was established on 30 December 1982 in Kanukunta Village, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230TG1982PLC003759. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹13.50 Cr and a paid-up capital of ₹13.50 Cr.
It upholds a compliant status. Its leadership includes Appala Charyulu Chilakanarri (Director), Subbaraju Gokaraju (Director), Yoganandavenkata Somayajulu Nuthi Subrahamanya (Managing Director). Past directors included Yoganandavenkata Somayajulu Nuthi Subrahamanya, Subbaraju Gokaraju, Gokaraju Ramaraju. It holds ₹53.00 Cr open charges and ₹11.00 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at Kanukunta Jinnaram Mandal, Kanukunta Village, Telangana, 502313.
U24230TG1982PLC003759
003759
30 December 1982
₹13.50 Cr
₹13.50 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sudershan Drugs And Intermediates Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Appala Charyulu Chilakanarri | Director | 15 May 2005 | Current |
| Subbaraju Gokaraju | Director | 30 Sep 1994 | Current |
| Yoganandavenkata Somayajulu Nuthi Subrahamanya | Managing Director | 22 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Chief Financial Officer | - | Past |
| Pramod Abcsdd | Managing Director | 01 Sep 2020 | Past |
| Pramod Abcsdd | Director | 20 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sudershan Drugs And Intermediates Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.77% increase. The company also saw a slight decrease in profitability, with a 8.95% decrease in profit. The company's net worth dipped by a decrease of 7.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sudershan Drugs And Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹530,000,000.00
₹110,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2000 | Gr Intrachem Ltd | ₹12.00 Cr | Open |
| 30 Mar 2000 | Gr Intrachem Ltd | ₹5.00 Cr | Open |
| 06 Dec 1997 | Canara Bank | ₹20.00 Cr | Open |
| 10 Mar 1995 | Gr Intrachem Ltd | ₹12.00 Cr | Open |
| 17 Jul 1993 | State Bank Of India | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sudershan Drugs And Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sudershan Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sudershan Drugs And Intermediates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sudershan Drugs And Intermediates Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was documented.
Progress on Sudershan Drugs And Intermediates Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
Subbaraju Gokaraju was appointed as a CFO was appointed as a CFO on 01 Sep 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
Progress on Priya Khetan was appointed as a Company Secretary was appointed as a Company Secretary on 13 Jun 2019 & has been associated with this company since 6 years 7 months . was documented.
Yoganandavenkata Somayajulu Nuthi Subrahamanya was appointed as a Managing Director was appointed as a Managing Director on 22 Dec 2017 & has been associated with this company since 8 years 25 days . was recorded as a recent event.
The activity A charge registered on 06 Mar 2000 via Charge ID 90124640 with The Banares State Bank Ltd was fully satisfied on 06 Dec 2008. was completed.
The CIN of Sudershan Drugs And Intermediates Limited is U24230TG1982PLC003759.
Sudershan Drugs And Intermediates Limited is headquartered at Kanukunta Jinnaram Mandal, Kanukunta Village, Telangana, 502313.
Sudershan Drugs And Intermediates Limited was incorporated on 30 December 1982.
The current directors of Sudershan Drugs And Intermediates Limited are
The primary industry of Sudershan Drugs And Intermediates Limited is Pharma.
Sudershan Drugs And Intermediates Limited is unlisted.
The authorized capital of Sudershan Drugs And Intermediates Limited is ₹13.50 Cr, and the paid-up capital is ₹13.50 Cr.
The compliance status of Sudershan Drugs And Intermediates Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX